Hereditary Factor X deficiency is an ultra-rare disorder affecting 400-600 patients in the US; private firm, BLP submitted a BLA for an FX plasma-derived replacement therapy called Coagadex (good name):
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.